Ligation of Intersphincteric Fistula Tract (LIFT) Procedure Versus Use of an Anal Fistula Plug for Anal Fistula Repair

NCT ID: NCT00830661

Last Updated: 2009-05-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

124 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Anal fistulae are a difficult problem to treat. The optimal treatment for fistula involving the anal sphincter is unclear. Two standardly used methods of treatment are the ligation of intersphincteric fistula track (LIFT) procedure and the use of an anal fistula plug. The purpose of this study is to exam the rate of fistula closure between the LIFT procedure and the use of a fistula plug

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anal Fistula

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

transsphincteric anal fistula cryptoglandular origin anal fistula repair Ligation of Intersphincteric Fistula Track (LIFT) procedure anal fistula plug (Plug) surgical repair

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LIFT

those subjects receiving the Ligation of Intersphincteric Fistula Track procedure

Group Type ACTIVE_COMPARATOR

Ligation of intersphincteric fistula track procedure

Intervention Type PROCEDURE

Subjects randomized to this arm will receive the ligation of the intersphincteric fistula track (LIFT) procedure. This procedure will be performed as per standard operating procedure.

Plug

those subjects randomized to the receive the placement of the porcine anal fistula plug

Group Type ACTIVE_COMPARATOR

anal fistula plug

Intervention Type PROCEDURE

placement of the porcine anal fistula plug as per the instructions for use in product packaging

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ligation of intersphincteric fistula track procedure

Subjects randomized to this arm will receive the ligation of the intersphincteric fistula track (LIFT) procedure. This procedure will be performed as per standard operating procedure.

Intervention Type PROCEDURE

anal fistula plug

placement of the porcine anal fistula plug as per the instructions for use in product packaging

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female subjects 18 years of age or older.
* Able to understand and provide informed consent or have a legally authorized representative capable of providing consent.
* Has a documented diagnosis, confirmed by physical exam and/or endorectal ultrasound (if available), of a trans-sphincteric fistula tract determined to be of cryptoglandular origin (primary or recurrent).

Exclusion Criteria

* History or suspicion of Inflammatory Bowel Disease (Crohn's or Ulcerative colitis).
* History of connective tissue disease.
* Rectovaginal fistula.
* Presence of horseshoe fistula.
* History of immunosuppression therapy/treatment within previous six months.
* Presents of a proximal diversion and refractory fistula.
* Any physical conditions, disease, or disorder that would exclude subject from being a candidate for elective surgery.
* Known history of allergy to pork or pork products.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Pennsylvania

OTHER

Sponsor Role collaborator

University of Ottawa

OTHER

Sponsor Role collaborator

Massachusetts General Hospital

OTHER

Sponsor Role collaborator

Colon and Rectal Surgery Associates, Ltd.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of Minnesota/Colon and Rectal Surgery Associates. Ltd

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Heather L Rossi, MD

Role: PRINCIPAL_INVESTIGATOR

University of Minnesota/Colon and Rectal Surgery Associates, Ltd.

Husein Moloo, MD

Role: PRINCIPAL_INVESTIGATOR

University of Ottawa

Joshua Bleier, MD

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania Health System

Liliana Bordeianou, MD

Role: PRINCIPAL_INVESTIGATOR

Massachusetts General Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status NOT_YET_RECRUITING

Colon and Rectal Surgery Associates, Ltd

Minneapolis, Minnesota, United States

Site Status RECRUITING

University of Pennsylvania Health System

Philadelphia, Pennsylvania, United States

Site Status RECRUITING

University of Ottawa

Ottawa, Ontario, Canada

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Deb J Jones, BS

Role: CONTACT

Phone: 651-225-7830

Email: [email protected]

Rachael Peterson, BS

Role: CONTACT

Phone: 651-225-7817

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Liliana Bordeianou, MD

Role: primary

Deb Jones, BS

Role: primary

Rachael Peterson, BS

Role: backup

Joshua Bleier, MD

Role: primary

Husein Moloo, MD

Role: primary

Jonathon Cook, PhD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SMG1108

Identifier Type: -

Identifier Source: org_study_id